Anthropic reports early results of Claude in six drug development partnerships
AIAnthropic says its life sciences team has run deep research partnerships with six drug developers over several months and has started its own discovery programs. The case studies report that Claude proposed a Generate Biomedicines CAR T-cell design about 70% shorter than standard, which in lab tests made immune cells produce roughly 10 times as many receptors.
AIWhy it matters.
The post reports concrete case results from six drug-development partners and its own programs, showing where Claude helped and where its limits remain, useful for judging AI's role in drug development.
Source details
Anthropic Research · anthropic.comPublished · added here
Original title: Early progress on accelerating drug development with Claude